SCHEMBL10632511

SCHEMBL10632511

CCc1[nH]c(=O)[nH]c1C(=O)c1cccnc1C#N

nearest known ligand 0.52

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 2/20 0.52
▸ PDE3A Q14432 2/20 0.52
▸ PDE4A P27815 14/20 0.47
▸ PDE4B Q07343 14/20 0.47
▸ PDE4C Q08493 14/20 0.47
▸ PDE4D Q08499 14/20 0.47
▸ POLB P06746 1/20 0.38
▸ PLCG1 P19174 1/20 0.36
▸ PARP1 P09874 1/20 0.33
▸ KDM4D Q6B0I6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7435632 0.82 PDE3B (0.57) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10632835 0.81 PDE3B (0.53) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7431462 0.81 PDE3B (0.56) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7436174 0.76 PDE3B (0.53) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10995312 0.76 PDE3B (0.59) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7425415 0.76 PDE3B (0.58) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7441966 0.74 PDE3B (0.57) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10636277 0.74 PDE3B (0.50) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7440629 0.74 PDE3B (0.59) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10632302 0.72 PDE3B (0.50) PDE3BPDE3APDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0118790-B1 NOVEL AROYLIMIDAZOLONES MERRELL DOW PHARMACEUTICALS INC. (US) 1988-07-06 — — EP disclosed
US-4552880-A Aroylimidazolones MERRELL DOW PHARMACEUTICALS INC. (US) 1985-11-12 — — US disclosed
EP-0118790-A1 Novel aroylimidazolones MERRELL DOW PHARMACEUTICALS INC. (US) 1984-09-19 — — EP disclosed
Send feedback